Apolipoprotein e genotype is associated with temporal and hippocampal atrophy rates in healthy elderly adults: A tensor-based morphometry study

Journal of Alzheimer's Disease

Volumn 23, Issue 3, 2011, Pages 433-442

  Lu, Po H ^a   Thompson, Paul M ^a   Leow, Alex ^a   Lee, Grace J ^a   Lee, Agatha ^a   Yanovsky, Igor ^b   Parikshak, Neelroop ^a   Khoo, Theresa ^a   Wu, Stephanie ^a   Geschwind, Daniel ^a   Bartzokis, George ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Aging; Alzheimer's disease; Apolipoprotein E; asymmetry; healthy elderly; hippocampus; magnetic resonance imaging; temporal lobe; tensor based morphometry; white matter

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON4; UNCLASSIFIED DRUG;

ADULT; AGED; AGING; ARTICLE; BRAIN ATROPHY; BRAIN MAPPING; BRAIN TISSUE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; FEMALE; GENOTYPE; HETEROZYGOSITY; HIPPOCAMPUS; HUMAN; MALE; MORPHOMETRICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TEMPORAL LOBE; TENSOR BASED MORPHOMETRY; THREE DIMENSIONAL IMAGING;

EID: 79951916915     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-101398     Document Type: Article

References (73)

1. Seshadri S, Drachman DA, Lippa CF (1995) Apolipoprotein E epsilon4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know. Arch Neurol 52, 1074-1079.
2. Ashford JW (2004) Apoe genotype effects on Alzheimer's disease onset and epidemiology. JMol Neurosci 23, 157-166.
3. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van DujinCM(1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. Apoe and Alzheimer Disease Meta Analysis Consortium. JAMA 278, 1349-1356. (Pubitemid 27449696)
4. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342, 697-699. (Pubitemid 23279761)
5. Raber J, Huang Y, Ashford JW (2004) ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging 25, 641-650. (Pubitemid 38686487)
6. Deary IJ, Whiteman MC, Pattie A, Starr JM, Hayward C, Wright AF, Visscher PM, Tynan MC, Whalley LJ (2004) Apolipoprotein E gene variability and cognitive functions at age 79: a follow-up of the Scottish mental survey of 1932. Psychol Aging 19, 367-371. (Pubitemid 38720884)
7. Staehelin HB, Perrig-Chiello P, Mitrache C, Miserez AR, Perrig WJ (1999) Apolipoprotein E genotypes and cognitive functions in healthy elderly persons. Acta Neurol Scand 100, 53-60. (Pubitemid 29292551)
8. Wilson RS, Bienias JL, Berry-Kravis E, Evans DA, Bennett DA (2002) The apolipoprotein E epsilon2 allele and decline in episodic memory. J Neurol Neurosurg Psychiatry 73, 672-677. (Pubitemid 35448851)
9. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC Jr, Rimmler JB, Locke PA, Conneally PM, Schmader KE, Small GW, Roses AD, Haines JL, Pericak-VanceMA(1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 7, 180-184. (Pubitemid 24174658)
10. Khachaturian AS, Corcoran CD, Mayer LS, Zandi PP, Breitner JC (2004) Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study. Arch Gen Psychiatry 61, 518-524. (Pubitemid 38620851)
11. den Heijer T, Oudkerk M, Launer LJ, van Duijn CM, Hofman A, Breteler MM (2002) Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology 59, 746-748.
12. Tohgi H, Takahashi S, Kato E, Homma A, Niina R, Sasaki K, Yonezawa H, Sasaki M (1997) Reduced size of right hippocampus in 39-to 80-year-old normal subjects carrying the apolipoprotein E epsilon4 allele. Neurosci Lett 236, 21-24. (Pubitemid 27492069)
13. Lemaitre H, Crivello F, Dufouil C, Grassiot B, Tzourio C, Alperovitch A, Mazoyer B (2005) No epsilon4 gene dose effect on hippocampal atrophy in a large MRI database of healthy elderly subjects. Neuroimage 24, 1205-1213. (Pubitemid 40164522)
14. Tupler LA, Krishnan KR, Greenberg DL, Marcovina SM, Payne ME, MacFall JR, Charles HC, Doraiswamy PM (2007) Predicting memory decline in normal elderly: genetics, MRI, and cognitive reserve. Neurobiol Aging 28, 1644-1656. (Pubitemid 47384943)
15. Cohen RM, Small C, Lalonde F, Friz J, Sunderland T (2001) Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology 57, 2223-2228. (Pubitemid 34016455)
16. Jak AJ, Houston WS, Nagel BJ, Corey-Bloom J, Bondi MW (2007) Differential cross-sectional and longitudinal impact of Apoe genotype on hippocampal volumes in nondemented older adults. Dement Geriatr Cogn Disord 23, 382-389. (Pubitemid 46897174)
17. Moffat SD, Szekely CA, Zonderman AB, Kabani NJ, Resnick SM (2000) Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype. Neurology 55, 134-136. (Pubitemid 30461016)
18. Du AT, Schuff N, Chao LL, Kornak J, Jagust WJ, Kramer JH, Reed BR, Miller BL, Norman D, Chui HC, Weiner MW (2006) Age effects on atrophy rates of entorhinal cortex and hippocampus. Neurobiol Aging 27, 733-740.
19. Schmidt H, Schmidt R, Fazekas F, Semmler J, Kapeller P, Reinhart B, Kostner GM (1996) Apolipoprotein E ε4 allele in the normal elderly: neuropsychologic and brain MRI correlates. Clin Genet 50, 293-299. (Pubitemid 27019657)
20. Reiman EM, Uecker A, Caselli RJ, Lewis S, Bandy D, de Leon MJ, De Santi S, Convit A, Osborne D, Weaver A, Thibodeau SN (1998) Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann Neurol 44, 288-291. (Pubitemid 28374124)
21. Bigler ED, Tate DF,Miller MJ, Rice SA, Hessel CD, Earl HD, Tschanz JT, Plassman B, Welsh-Bohmer KA (2002) Dementia, asymmetry of temporal lobe structures, and apolipoprotein E genotype: relationships to cerebral atrophy and neuropsychological impairment. J Int Neuropsychol Soc 8, 925-933. (Pubitemid 35355861)
22. Chen K, Reiman EM, Alexander GE, Caselli RJ, Gerkin R, Bandy D, Domb A, Osborne D, Fox N, Crum WR, Saunders AM, Hardy J (2007) Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates. Am J Psychiatry 164, 916-921. (Pubitemid 46972907)
23. Persson J, Lind J, Larsson A, Ingvar M, Cruts M, van Broeckhoven C, Adolfsson R, Nilsson LG, Nyberg L (2006) Altered brain white matter integrity in healthy carriers of the Apoe epsilon4 allele: a risk for AD? Neurology 66, 1029-1033. (Pubitemid 44044786)
24. Honea RA, Vidoni E, Harsha A, Burns JM (2009) Impact of Apoe on the healthy aging brain: a voxel-based MRI and DTI study. J Alzheimers Dis 18, 533-564.
25. Nierenberg J, Pomara N, Hoptman MJ, Sidtis JJ, Ardekani BA, Lim KO (2005) Abnormal white matter integrity in healthy apolipoprotein E epsilon4 carriers. Neuroreport 16, 1369-1372. (Pubitemid 41225212)
26. Bartzokis G, Lu PH, Geschwind DH, Edwards N, Mintz J, Cummings JL (2006) Apolipoprotein E genotype and agerelated myelin breakdown in healthy individuals: implications for cognitive decline and dementia. Arch Gen Psychiatry 63, 63-72. (Pubitemid 43037470)
27. Ashburner J, Friston KJ (2003) Morphometry. Human Brain Function, Academic Press.
28. Hua X, Leow AD, Levitt JG, Caplan R, Thompson PM, Toga AW (2007) Detecting brain growth patterns in normal children using tensor-based morphometry. Hum Brain Mapp 30, 209-219.
29. Hua X, Leow AD, Lee S, Klunder AD, Toga AW, Lepore N, Chou YY, Brun C, Chiang MC, Barysheva M, Jack CR Jr, Bernstein MA, Britson PJ, Ward CP, Whitwell JL, Borowski B, Fleisher AS, Fox NC, Boyes RG, Barnes J, Harvey D, Kornak J, Schuff N, Boreta L, Alexander GE, Weiner MW, Thompson PM, Alzheimer's Disease Neuroimaging, Initiative (2008) 3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry. Neuroimage 41, 19-34.
30. Gogtay N, Lu A, Leow AD, Klunder AD, Lee AD, Chavez A, Greenstein D, Giedd JN, Toga AW, Rapoport JL, Thompson PM (2008) Three-dimensional brain growth abnormalities in childhood-onset schizophrenia visualized by using tensorbased morphometry. Proc Natl Acad Sci U S A 105, 15979-15984.
31. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn., Washington, APA.
32. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56, 303-308. (Pubitemid 29120227)
33. Delis DC, Kramer JH, Kaplan E, Ober B (1987) The California Verbal Learning Test, The Psychological Corporation, San Antonio.
34. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
35. Shattuck DW, Leahy RM (2002) BrainSuite: an automated cortical surface identification tool. Med Image Anal 6, 129-142. (Pubitemid 35282822)
36. Sled JG, Zijdenbos AP, Evans AC (1998) A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 17, 87-97. (Pubitemid 128742012)
37. Mazziotta J, Toga A, Evans A, Fox P, Lancaster J, Zilles K, Woods R, Paus T, Simpson G, Pike B, Holmes C, Collins L, Thompson P, MacDonald D, Iacoboni M, Schormann T, Amunts K, Palomero-Gallagher N, Geyer S, Parsons L, Narr K, Kabani N, Le Goualher G, Boomsma D, Cannon T, Kawashima R, Mazoyer B (2001) A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos Trans R Soc Lond B Biol Sci 356, 1293-1322. (Pubitemid 32876067)
38. Leow AD, Yanovsky I, Chiang MC, Lee AD, Klunder AD, Lu A, Becker JT, Davis SW, Toga AW, Thompson PM (2007) Statistical properties of Jacobian maps and the realization of unbiased large-deformation nonlinear image registration. IEEE Trans Med Imaging 26, 822-832. (Pubitemid 46842917)
39. D'Agostino E, Maes F, Vandermeulen D, Suetens P (2003) A viscous fluid model for multimodal non-rigid image registration using mutual information. Med Image Anal 7, 565-575. (Pubitemid 37327992)
40. Wells WM 3rd, Viola P, Atsumi H, Nakajima S, Kikinis R (1996) Multi-modal volume registration by maximization of mutual information. Med Image Anal 1, 35-51. (Pubitemid 126421955)
41. Yanovsky I, Leow AD, Lee S, Osher SJ, Thompson PM (2007) Comparing registration methods for mapping brain change using tensor-based morphometry. Med Image Anal 13, 679-700.
42. Bullmore ET, Suckling J, Overmeyer S, Rabe-Hesketh S, Taylor E, Brammer MJ (1999) Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain. IEEE Trans Med Imaging 18, 32-42.
43. Nichols TE, Holmes AP (2002) Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp 15, 1-25. (Pubitemid 34020610)
44. Thompson PM, Hayashi KM, de Zubicaray G, Janke AL, Rose SE, Semple J, Herman D, Hong MS, Dittmer SS, Doddrell DM, Toga AW(2003) Dynamics of gray matter loss in Alzheimer's disease. J Neurosci 23, 994-1005. (Pubitemid 36206191)
45. Soininen H, Partanen K, Pitkanen A, Hallikainen M, Hanninen T, Helisalmi S, Mannermaa A, Ryynanen M, Koivisto K, Riekkinen P Sr (1995) Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E epsilon4 allele. Neurology 45, 391-392.
46. Geroldi C, Laakso MP, DeCarli C, Beltramello A, Bianchetti A, Soininen H, Trabucchi M, Frisoni GB (2000) Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer's disease: a volumetric MRI study. J Neurol Neurosurg Psychiatry 68, 93-96. (Pubitemid 30248668)
47. Plassman BL, Welsh-Bohmer KA, Bigler ED, Johnson SC, Anderson CV, Helms MJ, Saunders AM, Breitner JC (1997) Apolipoprotein E epsilon4 allele and hippocampal volume in twins with normal cognition. Neurology 48, 985-989.
48. Barnes LL,Wilson RS, Bienias JL, Schneider JA, Evans DA, Bennett DA (2005) Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry 62, 685-691. (Pubitemid 40973444)
49. Bigler ED, Lowry NJ, Anderson CV, Johnson SC, Terry J, Steed M (2000) Dementia, quantitative neuroimaging, and apolipoprotein E genotype. Am J Neuroradiol 21, 1857-1868.
50. Hashimoto M, Yasuda M, Tanimukai S, Matsui M, Hirono N, Kazui H, Mori E (2001) Apolipoprotein E epsilon4 and the pattern of regional brain atrophy in Alzheimer's disease. Neurology 57, 1461-1466. (Pubitemid 32995729)
51. Lehtovirta M, Laakso MP, Soininen H, Helisalmi S, Mannermaa A, Helkala EL, Partanen K, Ryynanen M, Vainio P, Hartikainen P, Riekkinen PJ Sr (1995) Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes. Neuroscience 67, 65-72.
52. Pedraza O, Bowers D, Gilmore R (2004) Asymmetry of the hippocampus and amygdala inMRIvolumetric measurements of normal adults. J Int Neuropsychol Soc 10, 664-678. (Pubitemid 39264092)
53. Gomez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, Parisi JE, Hyman BT (1997) Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol 41, 17-24. (Pubitemid 27057088)
54. Peters A, Morrison JH, Rosene DL, Hyman BT (1998) Are neurons lost from the primate cerebral cortex during normal aging? Cereb Cortex 8, 295-300. (Pubitemid 28280735)
55. Peters A (2002) Structural changes in the normally aging cerebral cortex of primates. Prog Brain Res 136, 455-465. (Pubitemid 35460999)
56. Kemper T (1994) Neuroanatomical and neuropathological changes during aging and dementia. In Clinical Neurology of Aging, Albert M, Knoefel J, eds., 2nd edn. Oxford University Press, New York.
57. Tang Y, Nyengaard JR, Pakkenberg B, Gundersen HJ (1997) Age-induced white matter changes in the human brain: a stereological investigation. Neurobiol Aging 18, 609-615. (Pubitemid 28046413)
58. Marner L, Nyengaard JR, Tang Y, Pakkenberg B (2003) Marked loss of myelinated nerve fibers in the human brain with age. J Comp Neurol 462, 144-152. (Pubitemid 36723664)
59. Peters A, Rosene DL, Moss MB, Kemper TL, Abraham CR, Tigges J, Albert MS (1996) Neurobiological bases of agerelated cognitive decline in the rhesus monkey. J Neuropathol Exp Neurol 55, 861-874. (Pubitemid 26287002)
60. Peters A, Sethares C, Killiany RJ (2001) Effects of age on the thickness of myelin sheaths in monkey primary visual cortex. J Comp Neurol 435, 241-248. (Pubitemid 32480010)
61. Bartzokis G, Sultzer D, Lu PH, Nuechterlein KH, Mintz J, Cummings J (2004) Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical "disconnection" in aging and Alzheimer's disease. Neurobiol Aging 25, 843-851. (Pubitemid 38813164)
62. Kochunov P, Thompson PM, Lancaster JL, Bartzokis G, Smith S, Coyle T, Royall DR, Laird A, Fox PT (2007) Relationship between white matter fractional anisotropy and other indices of cerebral health in normal aging: tract-based spatial statistics study of aging. Neuroimage 35, 478-487. (Pubitemid 46420428)
63. Bartzokis G (2004) Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging 25, 5-18. (Pubitemid 37522186)
64. Salat DH, Tuch DS, Greve DN, van der Kouwe AJ, Hevelone ND, Zaleta AK, Rosen BR, Fischl B, Corkin S, Rosas HD, Dale AM (2005) Age-related alterations in white matter microstructure measured by diffusion tensor imaging. Neurobiol Aging 26, 1215-1227. (Pubitemid 40726015)
65. Brun A, Englund E (1986) A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 19, 253-262. (Pubitemid 16111074)
66. Hyman BT, van HoesenGW, Kromer LJ, Damasio AR (1986) Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann Neurol 20, 472-481. (Pubitemid 16005665)
67. Beck KD, Powell-Braxton L, Widmer HR, Valverde J, Hefti F (1995) Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron 14, 717-730.
68. Abraham J, Vincze A, Jewgenow I, Veszpremi B, Kravjak A, Gomori E, Seress L (2010) Myelination in the human hippocampal formation from midgestation to adulthood. Int J Dev Neurosci 28, 401-410.
69. Cotel MC, Bayer TA, Wirths O (2008) Age-dependent loss of dentate gyrus granule cells in APP/PS1KI mice. Brain Res 1222, 207-213.
70. Boyles JK, Zoellner CD, Anderson LJ, Kosik LM, Pitas RE, Weisgraber KH, Hui DY, Mahley RW, Gebicke-Haerter PJ, Ignatius MJ (1989) A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest 83, 1015-1031. (Pubitemid 19080637)
71. Goodrum JF. Cholesterol from degenerating nerve myelin becomes associated with lipoproteins containing apolipoprotein E. J Neurochem 56, 2082-2086.
72. Poirier J (2005) Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease. Neurobiol Aging 26, 355-361. (Pubitemid 40082719)
73. Riddell DR, Zhou H, Atchison K,Warwick HK, Atkinson PJ, Jefferson J, Xu L, Aschmies S, Kirksey Y, Hu Y, Wagner E, Parratt A, Xu J, Li Z, Zaleska MM, Jacobsen JS, Pangalos MN, Reinhart PH (2008) Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels. J Neurosci 28, 11445-11453.